Golimumab Subcutaneous and Memantine Extended-Release Capsules
Determining the interaction of Golimumab Subcutaneous and Memantine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: memantine
Brand name: Namenda, Namenda XR
Synonyms: Memantine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Memantine Hydrochloride
- Golimumab Subcutaneous-Memantine Oral Solution
- Golimumab Subcutaneous-Memantine Solution
- Golimumab Subcutaneous-Memantine Tablets
- Golimumab Subcutaneous-Members Mark Cetirizine
- Golimumab Subcutaneous-Members Mark Loratadine
- Memantine Extended-Release Capsules-GoLYTELY
- Memantine Extended-Release Capsules-Gonadorelin
- Memantine Extended-Release Capsules-Gonadorelin Intravenous, Injection
- Memantine Extended-Release Capsules-Gonadotropin, Chorionic
- Memantine Extended-Release Capsules-Gonal-F
- Memantine Extended-Release Capsules-Gonal-f RFF